Open access
Aug 2026
Selective and Synergistic Targeting of ErbB2-Positive Cancer Cells with ErbB2 Transmembrane Peptide-Ionic Liquid Nanocarrier Formulation.
Findings establish TM peptide-decorated SAIL nanocarriers as a promising strategy for selective and synergistic ErbB2-targeted cancer therapy for selective targeting of ErbB2-positive cancer cells.
Helal Abujubara, Pankaj Bharmoria, Dorota Raj et al.
· ACS Applied Materials and In... · 0 citations